About Pluristem Therapeutics Inc. (PSTI) — Dividend Analysis 2026
Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA's Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel.
Is PSTI a good dividend investment in 2026?
PSTI offers a 200.00% forward yield with a 50% payout ratio. Strand Safety Score: 15/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
PSTI DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your PSTI portfolio grows to $48.73M vs $10.44M without reinvestment. This is the compound interest effect in action.
PSTI dividend growth history & forecast
PSTI has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 200.00%.
Company generates negative FCF ($-20M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.0B → -0.0B → -0.0B
15 / 30 pts
15/30
Net income grew in the latest year — positive but trend is unconfirmed
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
15
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 PSTI Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold PSTI.
Gross yield
200.00%
Tax rate
15.00%
After-tax yield
170.00%
Real yield (−CPI)
167.20%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
200.00%
197.20%
$20,000 / yr
🇺🇸 US Taxable (15%) ✓
15%
170.00%
167.20%
$17,000 / yr
🇺🇸 US Taxable (20%)
20%
160.00%
157.20%
$16,000 / yr
🇬🇧 UK ISA
0%
200.00%
197.20%
$20,000 / yr
🇬🇧 UK Taxable
8.75%
182.50%
179.70%
$18,250 / yr
🇨🇦 TFSA
0%
200.00%
197.20%
$20,000 / yr
🇨🇦 CA Taxable
25%
150.00%
147.20%
$15,000 / yr
🇦🇺 Super (pension)
15%
170.00%
167.20%
$17,000 / yr
🇦🇺 AU Taxable
30%
140.00%
137.20%
$14,000 / yr
🇩🇪 DE Taxable
26.375%
147.25%
144.45%
$14,725 / yr
🇫🇷 FR Taxable
30%
140.00%
137.20%
$14,000 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 PSTI Income Goal & Break-Even
Dividend Break-Even
1yr
Years for dividends to fully repay your PSTI investment of $1.00/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$534.7K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$532.2K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in PSTI for:
Shares needed
14,118
Capital required
$14,118
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 PSTI Dividend Payment Schedule
PSTI pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 PSTI vs Healthcare Benchmarks
How PSTI compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+197.20% vs sectorBetter
PSTI
200.00%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
PSTI
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
PSTI
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PSTI sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ PSTI Insider Activity
No recent SEC filings reported in the last 90 days.
🔬
Financial Health Scores
Altman Z-Score
-41.51
🔴 Distress Zone — elevated dividend cut risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
4/9
⚠️ Moderate fundamentals
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PSTI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →